about
Acute kidney injury in patients with chronic liver diseaseTransfusion and coagulation management in liver transplantationProtection against acute kidney injury via A(1) adenosine receptor-mediated Akt activation reduces liver injury after liver ischemia and reperfusion in mice.Renal dysfunction in chronic liver disease.Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failureOn-treatment mortality predictors in chronic hepatitis B patients experiencing severe acute exacerbation: a prospective observational studyStudy on assessment of renal function in chronic liver disease.Effectiveness of intravenous infusion of N-acetylcysteine in cirrhotic patients undergoing major abdominal surgeries.Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver DiseaseA Nonlinear Mixed Effects Pharmacokinetic Model for Dapagliflozin and Dapagliflozin 3-O-glucuronide in Renal or Hepatic Impairment.Acute kidney injury after hepatic ischemia and reperfusion injury in mice.Urinary bile casts in bile cast nephropathy secondary to severe falciparum malariaKidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injuryAcute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomographyThe effect of octreotide on urine output during orthotopic liver transplantation and early postoperative renal function; a randomized, double-blind, placebo-controlled trialAcute kidney injury in cirrhosis.Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.Acute kidney injury in acute liver failure: a review.Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.Global consequences of liver ischemia/reperfusion injury.Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics.Assessment of renal functions in patients of chronic liver disease.Acute renal dysfunction in patients with alcoholic hepatitis.[Volume replacement in intensive care medicine].The effect of kidney diseases on survival in liver transplant patients.The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States.Manifestation of multidrug resistance protein 3 (MRP3) in liver and kidney cells in cholestasis: effects of hyperprolactinemia.Prolactine receptor expression in kidney tissue of female rats with cholestasis: the effect of hyperprolactinemia.The Role of Urinary Neutrophil Gelatinase-Associated Lipocalin in Predicting Acute Kidney Dysfunction in Patients With Liver Cirrhosis.Bile cast nephropathy in a patient with cholangiocarcinoma - a case report.Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study
P2860
Q26824834-9426F602-EDC6-48C2-BA2F-A2CA9E099F2AQ26995591-34E003EC-4561-4875-BC69-5571AD73FD7BQ33890909-EC1B61FC-83D5-48CD-AB73-6AEB768596EAQ33918950-C544E4F5-3A8E-4655-9191-D7A556A93679Q34646645-C309FBEB-99AF-4FA7-983E-5E093C9FCD97Q34978162-FFCCDD2E-8B0C-4EC7-8DC5-D180E8874C73Q35548556-3E53551C-B0F1-45CA-A1A1-06524E7AEB37Q35774842-2053BC22-75AD-419D-B9AA-F244F27980BFQ35843192-86CAFA49-9D75-4178-8CF0-2BCE2D24BEBDQ36907014-30B50053-514D-4299-A743-F9AB636168A3Q37076990-90DADFCC-FF27-44E5-8312-1C313202B461Q37119062-5EDE0081-3EC0-42B2-849D-EDAA9D46673EQ37217259-DB97233B-C17C-4188-A2ED-5CBD0B84619EQ37300579-318126BC-0AF1-42AF-B509-47FC2780A0BAQ37315198-D82398B9-CD92-49E1-926E-32D91298B3B6Q37323711-9429A45E-C740-463B-9EFC-E07984D21B9DQ37624603-4DCFCCF2-D1B0-46D2-886B-FB7843280444Q38153420-82B1CE12-613B-4D02-99AB-4FE3928DF40EQ38194032-721364D4-F846-4F90-AEE1-D03535C97BFAQ38209664-9575AE13-8A27-44FB-AA8D-2B7414EC9781Q38632428-8D7D7C43-2642-4EC1-B837-9C5DAB5E2536Q39732824-DAC8B75B-9799-4C0A-84B4-A9DF17E0F0F5Q40901259-5A3CF230-31C6-4BA8-B640-027E2106D1A5Q41016725-9D273B11-D904-42C3-A316-48150FF23804Q42256541-79F1CDC8-D83A-4651-8EED-4EB654247117Q50162593-732B571A-F4C3-4F6E-825D-00BBD09228B3Q50567627-A033490F-D892-44C9-858D-1DFB29181FB2Q50643847-776A30FA-0CF8-4A87-8172-601AE08743D3Q51263932-AC3F17B9-A840-4527-BE97-C69FC4369D99Q51310806-3C4D3D44-E8FD-4C5C-9B06-EDAAEE0798A5Q52629210-A83509C4-6FE7-4153-866C-2EF38713807FQ54939686-31CA1F4F-1F07-40E0-8FAE-893E66FE9AA8Q57073583-702F428F-9096-4B13-80CD-7972DBDC6825
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Acute renal dysfunction in liver diseases
@en
type
label
Acute renal dysfunction in liver diseases
@en
prefLabel
Acute renal dysfunction in liver diseases
@en
P2093
P2860
P356
P1476
Acute renal dysfunction in liver diseases
@en
P2093
Alex-P Betrosian
Banwari Agarwal
Emmanuel E Douzinas
P2860
P304
P356
10.3748/WJG.V13.I42.5552
P407
P577
2007-11-01T00:00:00Z